Aviva’s share price drops despite forecast-beating results! Time to buy?

Aviva’s share price has fallen despite broad sales growth and a big jump in profits. Is now the time for investors to pile into the FTSE 100 company?

| More on:
Happy young female stock-picker in a cafe

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve long argued that Aviva‘s (LSE:AV.) share price is one of the best bargains on the FTSE 100. Sure, it’s risen 12% in value so far in 2024. Yet the financial services giant still looks dirt cheap across a variety of metrics.

At 485.2p per share, Aviva shares trade on a forward-looking price-to-earnings growth (PEG) ratio of 0.5. Any reading below 1 suggests a stock is undervalued.

On top of this, its 7.3% dividend yield is one of the best on the Footsie. By comparison, the index average sits way back at 3.6%.

Quite why the company’s THIS cheap is a mystery to me. So is the slight fall in its share price on Wednesday (14 August) despite the release of forecast-topping first-half results.

Strong numbers

Despite pressure from higher-than-normal interest rates, Aviva’s product ranges remained in high demand in the first half.

At its wealth, retirement and insurance divisions, sales rose 12% to £19.7bn in the six months to June. Meanwhile, general insurance premiums improved an impressive 15% year on year, to £6bn.

As a consequence, operating profit rose 14% from the same 2023 period, to £875m. Aviva’s Solvency II capital ratio remained strong at 205%, although down two percentage points year on year. Cash remittances rose 16% to £825m.

This encouraged it to hike the interim dividend 7%, to 11.9p per share.

Chief executive Amanda Blanc praised “another six months of excellent trading,” adding that “we have generated growth right across Aviva, thanks to our leading positions in attractive markets such as workplace pensions and general insurance in the UK and Canada.”

Positive outlook

While Aviva’s numbers are strong, it may struggle to keep this momentum up if interest rates fail to fall meaningfully. A potential US recession could also have a serious knock-on effect on its UK, Irish and Canadian operations.

But given the broader economic outlook, allied with growing appetite among central banks to cut rates, I think the firm’s looking good to continue growing profits. Some have even suggested it may be an ideal safe haven given ongoing investor nervousness.

etoro analyst Adam Vettese, for instance, says that “given topical concerns over volatility and macro factors perhaps injecting some uncertainty back into the market, Aviva seems like a pretty solid place for investors to shelter from such conditions.”

Aviva is also unwavering in what it believes it can achieve in the short term. It’s targeted annual operating profit of £2bn by 2026 — up from £1.7bn in 2023 — and cumulative cash remittances of £5.8bn between now and then.

Here’s what I’d do now

This year I’ve increased the number of Aviva shares I hold in my portfolio. When I have more cash to spend, I plan to continue splashing the cash on the FTSE firm.

I believe its long-term profits could surge as demographic changes fuel demand for its protection, wealth and retirement products. It has a cash-rich balance sheet too, which allows it to take full advantage through further strategic acquisitions and investment in existing operations.

High competition across its markets may provide challenges going forwards. But Aviva’s market-leading positions demonstrates its ability to effectively counter this threat. On balance I think it’s a great stock to consider buying, and especially at current rock-bottom prices.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has positions in Aviva Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 slow and steady dividend shares I’d buy for a winning portfolio

Our writer breaks down her approach to dividend shares and details two picks she’s a fan of to help build…

Read more »

Investing Articles

Hunting for growth stocks? This FTSE 250 stock could be a great buy for me!

Growth stocks come in all shapes and sizes. Our writer details one tech pick she believes could be a savvy…

Read more »

Investing Articles

How many Legal & General shares do I need to buy for a £100 monthly income?

Legal & General shares offer a market-leading dividend yield. Our writer analyses the investment case for this passive income superstar.

Read more »

Investing Articles

Is the GSK share price the biggest bargain on the FTSE 100?

The GSK share price is nearly 10% off its 52-week high, and this Fool is keen to take a closer…

Read more »

Investing Articles

Is it time to buy the FTSE 100’s most shorted stock?

Five investors have borrowed 5.66% of this FTSE 100 stock in the hope that it falls in value. Our writer’s…

Read more »

Newspaper and direction sign with investment options
Investing Articles

Rightmove and Rentokil are 2 FTSE 100 shares in the news. Should I buy?

Two FTSE 100 shares hit the headlines today (11 September) for very different reasons. Our writer ponders whether now could…

Read more »

Couple working from home while daughter watches video on smartphone with headphones on
Dividend Shares

2 FTSE 250 income icons yielding above 6% that could pay me cash for life

Jon Smith runs through two different FTSE 250 income shares that have both paid continuous dividends for at least the…

Read more »

Happy parents playing with little kids riding in box
Investing Articles

With these 3 growth stocks, I’m hoping to build generational wealth

Edward Sheldon believes these three growth stocks are capable of generating spectacular returns for his portfolio over the next few…

Read more »